Glycated hemoglobin independently or in combination with fasting plasma glucose versus oral glucose tolerance test to detect abnormal glycometabolism in acute ischemic stroke: a Chinese cross-sectional study

Table 2 HbA1c and FPG versus OGTT in diagnosing abnormal glycometabolic status

		AUROC	Standard error	95% CI	P	Sensiti-vity	Specif-icity	Youden index
HbA1c	DM	0.692	0.018	0.657-0.726	<0.001	0.528	0.855	0.383
	Prediabetes	0.557	0.017	0.523-0.590	0.001	0.419	0.695	0.114
	AGM	0.648	0.016	0.617-0.678	<0.001	0.711	0.585	0.296
FPG	DM	0.652	0.019	0.616-0.689	<0.001	0.365	0.940	0.305
	Prediabetes	0.515	0.017	0.481-0.548	0.388	0.273	0.756	0.029
	AGM	0.654	0.015	0.624-0.684	<0.001	0.521	0.787	0.308
HbA1c	DM	0.712	0.017	0.678-0.745	<0.001	0.607	0.817	0.424
With FPG	Prediabetes	0.554	0.017	0.521-0.587	0.001	0.579	0.530	0.109
	AGM	0.650	0.015	0.623-0.681	<0.001	0.812	0.488	0.300

HbA1c indicates glycated hemoglobin; FPG indicates fasting plasma glucose; OGTT indicates oral glucose tolerance test; AUROC indicates the area under the receiver operating characteristic curve; CI indicates confidence interval; AGM indicates abnormal glucose metabolism.

ISSN: 1471-2377